← Eichor
Study identifier: NCT07054944 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Tumor-Lymph Node Mapping

Condition: Pediatric Solid Tumors · Rhabdomyosarcoma · Sarcoma  ·  Sponsor: University of Rochester

PhaseN/A
Planned participants10
Who can joinAll sexes, 1 Month to 17 Years
Healthy volunteersNo

About this study

The purpose of this study is to assess the feasibility and safety of ICG-guided intraoperative lymphography for detecting sentinel lymph nodes (SLN) in pediatric patients with solid tumors who require retroperitoneal lymph node dissection/sampling. This trial is a single-site cross-sectional study. The injection of ICG directly into lymphatics draining the primary tumor will take place at the time of operation after the patient is under anesthesia.

This description comes directly from the study's public registry record.

Talk to the study team

Abdelhafeez Abdelhafeez, MD  ·  Abdelhafeez_Abdelhafeez@URMC.Rochester.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Rochester Medical CenterRochester, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07054944